
The US generics market has shown a solid growth during the past few years backed by factors, such as government support, increasing awareness level, patent expiry of blockbuster drugs, price differences, and aging population. The generic drugs industry in the US stood at US$ 74 Billion in 2009, and is likely to grow further at a CAGR of around 10% during 2010-2013. In value terms, generic drugs had a share of around 25% in the total US pharmaceutical market during 2009, which is expected to reach around 28% by 2013. All this and various other analyses have been covered in our latest report entitled “Booming US Generic Drug Market”.